This inventor holds 1 USPTO granted patent. Top assignees: Chu De Bordeaux, National Institute of Health and Medical Research, Toyama Chemical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1,853 
1 out of 159 
Years Active: 2018
Title: Hervé Raoul: Innovator in Ebola Virus Treatment
Introduction
Hervé Raoul is a notable inventor based in Lyons, France. He has made significant contributions to the field of medicine, particularly in the treatment of Ebola Virus Disease. His innovative approach has led to the development of pharmaceutical compositions that aim to combat this deadly virus.
Latest Patents
Hervé Raoul holds 1 patent for his invention titled "Methods and pharmaceutical compositions for the treatment of Ebola virus disease." This patent focuses on methods of treating Ebola Virus Disease in subjects by administering a therapeutically effective amount of Favipiravir. His work is crucial in the ongoing fight against this infectious disease.
Career Highlights
Throughout his career, Hervé Raoul has been associated with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Bordeaux. His research and innovations have garnered attention and respect in the scientific community.
Collaborations
Hervé Raoul has collaborated with esteemed colleagues, including Denis Malvy and Sylvain Baize. These partnerships have furthered his research and contributed to advancements in the treatment of viral diseases.
Conclusion
Hervé Raoul's contributions to the medical field, particularly in the treatment of Ebola Virus Disease, highlight his role as an innovative inventor. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile